Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2012; 18(19): 2334-2343
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2334
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2334
Figure 8 Apoptosis induced by 5-aza-2’-deoxycitidine.
SMMC-7721 and HepG2 cells were treated with 2 μmol/L DAC, 20 μmol/L cisplatin, or in combination for 72 h. A: The fluorescent microscopic pictures of apoptotic cells were captured by 4’,6-diamidino-2-phenylindole staining of the condensed and fragmented nuclei; B, C: Annexin V-fluorescein isothiocyanate (FITC) staining following facial action coding system analysis was shown for SMMC-7721 (B) or HepG2 cells (C). DAC: 5-aza-2’-deoxycitidine; Con: Control; CDDP: Cisplatin.
- Citation: Tao SF, Zhang CS, Guo XL, Xu Y, Zhang SS, Song JR, Li R, Wu MC, Wei LX. Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. World J Gastroenterol 2012; 18(19): 2334-2343
- URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2334